← back to search

Ferdinand Hofstädter

University of Regensburg · DE
Area of research
Surgery · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Breast cancer, Gynecology, Internal medicine, Cancer, and Oncology.
h-index
citations
1,484
works
42
NIH funding
primary concept
email

Recent publications

Data from Microsatellite Instability Predicts Poor Short-Term Survival in Patients with Advanced Breast Cancer after High-Dose Chemotherapy and Autologous Stem-Cell Transplantation
2023cited by 0position: middledoi
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
World Journal of Urology 2020cited by 0position: middledoi
Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology
Breast Cancer Research and Treatment 2017cited by 35position: middledoi
Die screening-relevante Altersgrenze von ≥70 Jahren ist entscheidender für die Durchführung einer adjuvanten Therapie als die Tumorbiologie bei Patientinnen mit Mammakarzinom
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2017cited by 0position: middledoi
Gelingt die tumorbiologische Subtypisierung bei Patientinnen mit Mammakarzinom in der klinischen Routine? – Ergebnisse einer großen Kohorte eines klinischen Krebsregisters
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2016cited by 0position: middledoi
Brustkrebssubtypen und Überleben – Analyse von Daten aus einem klinischen Krebsregister
Geburtshilfe und Frauenheilkunde 2016cited by 0position: middledoi
Gelingt die tumorbiologische Subtypisierung bei Patientinnen mit Mammakarzinom in der klinischen Routine? – Ergebnisse einer großen Kohorte eines klinischen Krebsregisters
Geburtshilfe und Frauenheilkunde 2016cited by 0position: middledoi
4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival
Breast Cancer Research and Treatment 2015cited by 66position: middledoi
White-Light or Narrow-Band Imaging Colonoscopy in Surveillance of Ulcerative Colitis: A Prospective Multicenter Study
Clinical Gastroenterology and Hepatology 2015cited by 59position: middledoi
Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy
Journal of Cancer Research and Clinical Oncology 2015cited by 47position: middledoi
Epithelial–mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma
World Journal of Urology 2015cited by 41position: middledoi
Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
BMC Cancer 2015cited by 25position: middledoi
Direct improvement of quality of life in colorectal cancer patients using a tailored pathway with quality of life diagnosis and therapy (DIQOL): study protocol for a randomised controlled trial
Trials 2015cited by 18position: middledoi
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin – A multicenter study
Radiotherapy and Oncology 2015cited by 18position: middledoi
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
World Journal of Urology 2015cited by 18position: middledoi
Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry
Journal of Cancer Research and Clinical Oncology 2015cited by 13position: middledoi
Adjuvante endokrine Therapie bei Patientinnen mit hormonrezeptor-positivem Mammakarzinom – Ergebnisse einer großen bevölkerungsbezogenen Kohorte eines klinischen Krebsregisters
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2015cited by 0position: middledoi
Adjuvante endokrine Therapie bei Patientinnen mit Hormonrezeptor-positivem Mammakarzinom – Ergebnisse einer großen bevölkerungsbezogenen Kohorte eines klinischen Krebsregisters
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2015cited by 0position: middledoi
Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry
BioMed Research International 2014cited by 33position: middledoi
Outcome of Patients with Pathological Tumor Stage T3 Urothelial Carcinoma of the Bladder following Radical Cystectomy in a Single-Center Series with 116 Patients
Urologia Internationalis 2014cited by 10position: middledoi
Abstract 5004: Iqgap2 is downregulated in colorectal cancer (crc) and involved in cellular migration
Cancer Research 2014cited by 1position: middledoi
Eine leitliniengerechte Therapie verbessert das Gesamtüberleben von HER2-positiven Mammakarzinom-Patientinnen – Daten einer bevölkerungsbezogenen Kohorte eines Klinischen Krebsregisters
Geburtshilfe und Frauenheilkunde 2014cited by 0position: middledoi
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
Breast Cancer Research and Treatment 2013cited by 605position: middledoi
Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage
World Journal of Urology 2013cited by 29position: middledoi
Introduction and First Clinical Application of a Simplified Immunohistochemical Validation System Confirms Prognostic Impact of KI-67 and CK20 for Stage T1 Urothelial Bladder Carcinoma: Single-Center Analysis of Eight Biomarkers in a Series of Three Hundred Six Patients
Clinical Genitourinary Cancer 2013cited by 27position: middledoi
Ki‐67, mini‐chromosome maintenance 2 protein ( <scp>MCM2</scp> ) and geminin have no independent prognostic relevance for cancer‐specific survival in surgically treated squamous cell carcinoma of the penis
British Journal of Urology 2013cited by 26position: middledoi
Leitlinienkonforme Therapie der Frau mit HER2-positivem primärem Mammakarzinom? - Ergebnisse aus dem klinischen Krebsregister des Tumorzentrums Regensburg
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2013cited by 0position: middledoi
Vergleich ungezielter mit gezielter Probeentnahme sowie Weißlicht - mit NBI Koloskopie zur Krebsvorsorge bei Patienten mit langjähriger Colitis ulcerosa („Detect Dysplasia“)
Zeitschrift für Gastroenterologie 2013cited by 0position: middledoi
Follow-up study of a randomized clinical trial with quality of life diagnosis and therapy: Long-term quality of life of breast cancer survivors.
Journal of Clinical Oncology 2013cited by 0position: middledoi
Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer
European Urology 2012cited by 104position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Monika Klinikhammer-Schalke · University of Regensburg19 papers (2012–2017)Olaf Ortmann · University of Regensburg13 papers (2013–2017)EC Inwald · Klinik für Frauenheilkunde12 papers (2012–2017)Wolfgang Otto · University of Regensburg12 papers (2012–2015)Florian Zeman · University of Regensburg12 papers (2013–2017)Stefan Denzinger · University of Regensburg12 papers (2012–2015)M Gerstenhauer · University of Regensburg11 papers (2013–2016)Michael Koller · University Hospital Regensburg11 papers (2012–2017)Wolf F. Wieland · University of Regensburg10 papers (2012–2014)Maximilian Burger · University of Regensburg8 papers (2012–2015)Hans‐Martin Fritsche · University of Regensburg7 papers (2012–2014)Arndt Hartmann · Methodist University7 papers (2012–2023)Matthias May · Caritas-Krankenhaus St. Josef7 papers (2012–2015)Patricia Lindberg · University of Regensburg6 papers (2012–2015)Atiqullah Aziz · University of Regensburg5 papers (2012–2015)Gero Brockhoff · University of Regensburg5 papers (2015–2017)W. Lorenz · Klinikum Arnsberg4 papers (2012–2015)Brunhilde Steinger · University of Regensburg4 papers (2012–2015)Christian Giedl · University of Regensburg4 papers (2012–2015)Wolfgang Rößler · University of Regensburg4 papers (2012–2014)